Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coated Suppositories for Fecal Incontinence in Spinal Cord Injury
NCT01297608Phase 2Withdrawn
- Sponsor
- RDD Pharma
- Start
- Apr 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fecal incontinence (FI) comparing Phenylephrine Suppository with Placebo Suppository (2 arms). Primary endpoint: Difference in fecal incontinence at 2 weeks. Planned start Apr 2011; status: withdrawn.
02
Drugs
phenylephrine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT01297608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297608.